Rubella seroprofile of the Italian population: an 8-year comparison

M C Rota1, A Bella, G Gabutti

  • 1Centro Nazionale di Epidemiologia, Sorveglianza e Promozione della Salute, Istituto Superiore di Sanità, Rome, Italy. mariacristinarota@iss.it

Insights

Increasing measles, mumps, and rubella (MMR) vaccination in Italy boosted rubella immunity in children but not in women of childbearing age. Continued efforts are needed to prevent congenital rubella syndrome.

Area of Science:

  • Epidemiology
  • Immunology
  • Public Health

Background:

  • Rubella remains a public health concern, particularly regarding congenital rubella syndrome.
  • Measles, Mumps, and Rubella (MMR) vaccination is crucial for rubella prevention.
  • Understanding the impact of vaccination coverage on rubella epidemiology is vital for public health strategies.

Purpose of the Study:

  • To evaluate the impact of increased MMR infant vaccination coverage on rubella epidemiology in Italy.
  • To compare rubella antibody seroprevalence in Italy between 1996 and 2004.

Main Methods:

  • A cross-sectional population-based seroprevalence study was conducted.
  • 3094 serum samples were analyzed for rubella antibodies in 2004.
  • Results were compared with historical data from 1996 using the same methodology.

Main Results:

  • Overall rubella seropositivity significantly increased from 77.4% in 1996 to 84.6% in 2004.
  • This increase in seropositivity was confined to the 1-19 years age groups.
  • Seroprevalence in women of childbearing age did not significantly improve; over 5% remained susceptible.

Conclusions:

  • Recent increases in childhood MMR vaccination have not adequately impacted rubella seroprevalence in women of childbearing age.
  • A significant proportion of women remain susceptible to rubella, posing a risk for congenital rubella syndrome.
  • Preconception screening and postpartum vaccination are essential to achieve WHO targets for congenital rubella syndrome elimination.

Related Concept Videos

Prevalence and Incidence01:08

Prevalence and Incidence

In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health condition at a...
Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Respiratory Syncytial Virus Disease01:29

Respiratory Syncytial Virus Disease

Human respiratory syncytial virus (RSV) is a widespread pathogen that primarily targets infants and young children but also poses a serious health risk to elderly and immunocompromised individuals. Belonging to the Pneumoviridae family, RSV is a negative-sense, single-stranded RNA virus within the Pneumovirus genus. Its global health burden is significant, with millions of cases annually resulting in hospitalizations and mortality, particularly in resource-limited settings. Although most...
Vaccinations01:51

Vaccinations

Overview
Bias in Epidemiological Studies01:29

Bias in Epidemiological Studies

Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
Teratogenicity01:07

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...